Skip to content

RLMDRELMADA THERAPEUTICS INC

CUSIP 75955J402 · common stock

1 tracked investor held RELMADA THERAPEUTICS INC (RLMD) at the end of Q3 2026, worth $2.1M. The largest holder was Adar1 Capital Management, with 0.1% of its portfolio.

Holders · Q3 2026
1
New holders
0
Value held
$2.1M
Quarter-end price (est.)
$3.77

Investors holding RLMD · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.09%551,918$2.1MADD+22.1%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026100$2.1M$3.77
Q2 2026101$3.1M$6.92
Q1 2026210$23.7M$6.96
Q4 2025100$149.1K$4.83